3 news items
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
FENC
14 May 24
difficult, and sub-optimal cochlear (inner ear) implants have been shown to provide some benefit. Infants and young children that suffer ototoxicity
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
FENC
17 Mar 24
Pharmaceuticals. "From a deal perspective, the terms provided us many important benefits, including an upfront payment further solidifying our balance sheet
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
FENC
29 Feb 24
been shown to provide some benefit. Infants and young children that suffer ototoxicity at critical stages of development lack speech language
- Prev
- 1
- Next